1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A rare CALR exon 9 mutation p.E379Vfs*53 in AYA generation exhibits gain-of-function nature and can induce essential thrombocythemia; a case report
- Contribution to journal › Article
- 2024
-
Mark
Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation
- Contribution to journal › Article
